Shows
DKBmed RadioCF and Diet and Nutrition: The Changing ParadigmIndividuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments — HEMT — changed that situation? That’s the focus of this eCysticFibrosis Review Special Edition: CF and Nutrition and HEMT. The first part of this program presented an evidence-based Expert Commentary on the current status of weight gain, obesity, and nutrition among people with CF by guest author Katie McDonald, PhD, MS, RDN, CSP, a clinical dietitian at Primary Children's Medical Center in Salt Lake City. The second part i...2022-12-2338 min
eCysticFibrosis ReviewCF and Diet and Nutrition: The Changing ParadigmIndividuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments — HEMT — changed that situation? That’s the focus of this eCysticFibrosis Review Special Edition: CF and Nutrition and HEMT. The first part of this program presented an evidence-based Expert Commentary on the current status of weight gain, obesity, and nutrition among people with CF by guest author Katie McDonald, PhD, MS, RDN, CSP, a clinical dietitian at Primary Children's Medical Center in Salt Lake City. The second part i...2022-12-2338 min
DKBmed RadioETI (CFTR Triple Therapy): Clinical OpportunitiesThe advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit? Join us as we explore these questions with guest author Professor Edward McKone MD, from St. Vincent’s University Hospital and University College Dublin School of Medicine, in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted...2022-09-1428 mineCysticFibrosis ReviewETI (CFTR Triple Therapy): Clinical OpportunitiesThe advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit? Join us as we explore these questions with guest author Professor Edward McKone MD, from St. Vincent’s University Hospital and University College Dublin School of Medicine, in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted...2022-09-1428 min
DKBmed RadioPulmonary Exacerbations and IV AntibioticsManaging pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care? Join us for this eCysticFibrosis Review podcast, as Dr. D.B. Sanders from the Indiana University School of Medicine explains how these questions can affect clinical care. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.2022-07-2018 mineCysticFibrosis ReviewPulmonary Exacerbations and IV AntibioticsManaging pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care? Join us for this eCysticFibrosis Review podcast, as Dr. D.B. Sanders from the Indiana University School of Medicine explains how these questions can affect clinical care. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.2022-07-2018 min
DKBmed RadioRace, Ethnicity, and Cystic FibrosisRace and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes? That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.2022-06-2122 mineCysticFibrosis ReviewRace, Ethnicity, and Cystic FibrosisRace and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determinants of health limit access to appropriate CF treatment and produce poorer outcomes? That’s what we’re here to talk about today with Dr. Jennifer Taylor-Cousar from National Jewish Health and Children’s Hospital Colorado in this eCysticFibrosis Review podcast. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy for more information.2022-06-2122 mineCysticFibrosis ReviewThe Pancreas, Malnutrition, and CFTR ModulatorsPancreatic insufficiency. In children with CF, it’s been associated with delayed development and increased odds of developing severe lung disease. How can it be more accurately diagnosed? And what does the evidence say about the effects of treatment with CFTR modulators?That’s what we explore in this case-based podcast, with Dr. Vikesh Singh, Associate Professor of Medicine and Director of the Pancreatitis Center at Johns Hopkins Medical Institutions. Take our post-test to claim CME credits.Read this podcast's companion newsletter here. Hosted on Acast. See acast.com/privacy fo2021-03-2314 min
eCysticFibrosis ReviewCF and COVID-19: The Data and the Real WorldDo cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown? These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue. Lisa Saiman MD, MPH, professor of pediatrics at Columbia University Irving Medical Center, analyzes the curr...2020-12-1734 min
eCysticFibrosis ReviewOvercoming Shutdown ChallengesDo cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown? These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue. Hosted on Acast. See acast.com/privacy for more informat2020-12-0708 min
eCysticFibrosis ReviewManaging Psychosocial and Economic StressDo cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown? These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue. Hosted on Acast. See acast.com/privacy for more informat2020-12-0706 min
eCysticFibrosis ReviewMaintaining CF Infection Prevention and ControlDo cystic fibrosis lung impairment and the COVID-19 virus create the disastrous combination they would seem to make? What do the currently published data say about the clinical effects of the pandemic on people living with CF? How have the safety-mandated lockdowns and clinic closures affected CF care teams’ ability to effectively maintain their patients’ health? What information out there is proved, what’s speculation, and what is simply unknown? These questions are the focus of this eCysticFibrosis Review Special COVID Edition issue. Hosted on Acast. See acast.com/privacy for more informat2020-12-0705 min
eCysticFibrosis ReviewClinical Considerations for Women with CFStudies have shown that adolescent and young adult women with cystic fibrosis often turn to their CF care team for answers to their questions about their sexual and reproductive health. But how prepared are CF clinicians to initiate conversations? Do they have the most current data about pregnancy decisions for women taking CFTR modulators? When should modulator therapy be stopped? When is it safe to continue?In this eCysticFibrosis Review podcast, Dr. Traci Kazmerski from UPMC Children's Hospital of Pittsburgh and Dr. Natalie West from Johns Hopkins University take us into the clinic to address these important...2020-11-2817 min
eCysticFibrosis ReviewAntibiotics, Dosing, and CFTRAirway infections are a hallmark of cystic fibrosis, making antibiotic therapies a mainstay of CF treatment. While the fight against ABX resistance is ongoing, newer data are showing that commonly used dosing regimens may have to be altered to account for the particular pharmacodynamics in people with CF. How should ABX dosing be altered, and what additional effect might CFTR modulation have on dosing decisions?That’s the topic Dr. Andrea Hahn, Assistant Professor of Pediatrics and an Infectious Disease Specialist at Children’s National Medical Center and George Washington University School of Medicine and Health...2020-09-3017 min
eCysticFibrosis ReviewBringing Telemedicine to the CF Clinic: A Success StoryNo-contact telemedicine to better protect CF clinic patients and staff during this pandemic may sound like a great idea, but is it even possible to institute? In this eCysticFibrosis Review Special Edition podcast, we find out how pulmonary and critical care specialists Dr. Dana Albon and Dr. Lindsay Somerville successfully brought telemedicine to their Adult Cystic Fibrosis Clinic at University of Virginia Health.Take our post-test to claim CME credits. Hosted on Acast. See acast.com/privacy for more information.2020-09-0224 min
eCysticFibrosis ReviewCFTR, Growth & Liver Disease: A Clinical PerspectiveWhere, beyond the lungs, do CFTR modulators provide beneficial effects? Can treatment promote growth in height and BMI? What’s known about CFTR modulator effects on cystic fibrosis-associated liver disease? In this eCysticFibrosis Review podcast, Drs. Darla Shores and Anna Reed from the THRIVE Pediatric Intestinal Rehabilitation Center in the Division of Gastroenterology, Hepatology, and Nutrition at the Johns Hopkins Children's Center take us to the clinic to answer these and other questions crucial to the health of our patients with cystic fibrosis.Take our post-test to claim CME credits.To read a comp...2020-08-0320 min
eCysticFibrosis ReviewIn the Clinic: Triple Combination CFTR ModulationElexacaftor/tezacaftor/ivacaftor — the newly approved triple combination CFTR modulator therapy. What are the benefits? For which patients? What are the potential adverse effects? Who’s most likely to receive them? In this issue, Dr. Scott Sagel from the Breathing Institute at the Children’s Hospital Colorado, part of the University of Colorado’s Anschutz Medical Campus, takes us to the clinic to discuss some answers.Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.2020-06-0225 min
eCysticFibrosis ReviewAddressing Mental Health in CFAnxiety and depression in cystic fibrosis — who do these conditions affect? How much do they influence patient health? How can clinicians identify and manage them? What evidence-based interventions have been shown to work?In this issue, Dr. Anna Georgiopoulos, Assistant Professor of Psychiatry, Part-Time, Harvard Medical School and Consulting Psychiatrist, Massachusetts General Hospital Cystic Fibrosis Program, takes us to the clinic to answer these questions that can be key to the health and well-being of children, adults, and families living with CF.Take our post-test to claim CME credits.To r...2020-05-0520 min
eCysticFibrosis ReviewClinical Considerations: New Anti-Inflammatories & New CFTR ModulatorsNew CFTR modulators for F508del mutations? New research into reducing inflammation in the CF lung? In this issue, Dr. Jennifer Taylor-Cousar from National Jewish Health in Denver explains the potential clinical impact of new and emerging CF disease modifying therapies.Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.2019-10-1121 min
eCysticFibrosis ReviewContinuous Alternating Therapies: A Clinical PerspectiveInhaled antibiotics have become the foundation of treating chronic respiratory tract Pseudomonas infection in individuals with cystic fibrosis. But what happens when inhaled monotherapy doesn’t sufficiently manage the symptoms? Which patients are appropriate candidates for treatment with multiple inhaled agents? Which medications are appropriate for continuous alternating therapy (CAT)?In this Issue, Dr. Elliott Dasenbrook from the Cleveland Clinic brings the evidence he analyzed in his recent eCysticFibrosis Review Newsletter issue (Vol 8; Issue 10) into the clinic to help guide clinical decision-making.Take our post-test to claim CME credits. To read...2019-08-1021 min
eCysticFibrosis ReviewIn The Clinic: CFTR Modification & Nutritional DeficienciesThe effects of CFTR modifiers on improving lung function in people with cystic fibrosis are well known. But what about their effects on the GI tract that directly affect nutrition?In this issue, Dr. Michael Wilschanski — Director of Hadassah Hospital’s Pediatric Gastroenterology Unit at Hebrew University in Jerusalem — explains how new findings about CFTR modification can impact clinical practice. Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.2019-06-2117 mineCysticFibrosis ReviewNTM Infection: Today's Treatments & New Antibiotics in DevelopmentVolume 8, Issue 7. Part 3 Hosted on Acast. See acast.com/privacy for more information.2019-05-0703 mineCysticFibrosis ReviewNTM Infection: Risk of Patient-to-Patient Transmission in CF CentersVolume 8, Issue 7. Part 2 Hosted on Acast. See acast.com/privacy for more information.2019-05-0703 mineCysticFibrosis ReviewNTM Infection: Risks of Acquisition from the EnvironmentVolume 8, Issue 7. Part 1 Hosted on Acast. See acast.com/privacy for more information.2019-05-0704 min
eCysticFibrosis ReviewClinical Insight: CFTR ModulatorsIn this issue, Dr. Gregory Sawicki — Associate Professor of Pediatrics at Harvard Medical School and Director of the Cystic Fibrosis Center at Boston Children’s Hospital — discusses how the recent findings about the real-world use of CFTR modulators can impact clinical practice.Take our post-test to claim CME credits. To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.2019-03-0828 min
eCysticFibrosis ReviewClinical Approaches to MDR Lung InfectionsMultidrug resistant lung infections present an increasingly common and increasingly dangerous threat to all individuals with cystic fibrosis. Common CF pathogens — Pseudomonas aeruginosa, Burkholderia cepacia complex, Achromobacter xylosoxidans, Stenotrophomonas maltophilia — are all showing increasing resistance to clinicians’ usual antibiotic armamentarium.In this issue, Dr. Claire Elson, from the University of Missouri Kansas City School of Pharmacy, and Dr. Christopher Oermann, from the UMKC School of Medicine, describe strategies for the clinical management of these resistant infections.Take our post-test to claim CME credits.To read a companion newslette...2019-01-1822 min
eCysticFibrosis ReviewLung Transplant and CRC ScreeningScreening to avoid the morbidity and mortality of colorectal cancer (CRC) in patients with CF, with the incidence of CRC rising, has become an increasingly important challenge, particularly among lung transplant patients. But how and when should patients be screened? With colonoscopy or non-invasive FIT? Before or after transplant? Are there patients who should not be screened, and why?In this issue, Dr. Denis Hadjiliadis from the Perelman School of Medicine at the University of Pennsylvania discusses the clinical aspects of screening patients with CF to prevent CRC.Take our post-test to...2018-10-2625 mineCysticFibrosis ReviewCFTR Modulators: Clinical InsightsVolume 7, Issue 12.In this podcast Dr. John P. Clancy reviews CFTR modulators, and discusses insights presented at the 2017 NACFC.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post CFTR Modulators: Clinical Insights appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2018-02-0331 mineCysticFibrosis ReviewScreening and Diagnosis of CFRDVolume 7, Issue 10.In this podcast Andrea Granados, MD describes the clinical impact of the early diagnosis of glucose abnormalities in people with CF, summarizes the limitations of alternative modalities for screening and diagnosing CFRD, and and identifies the current recommendations for the management of CFRD.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Screening and Diagnosis of CFRD appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2017-10-2733 mineCysticFibrosis ReviewNew Directions in CFTR ModificationVolume 7, Issue 8.In this podcast Dr. George Solomon discusses new directions in CFTR modification in the context of case studies.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post New Directions in CFTR Modification appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2017-09-0830 mineCysticFibrosis ReviewNutritional Management for Individuals with CF: Practical ApplicationsVolume 7, Issue 6.Our guest author is Amanda Leonard, MPH, RD, CDE, from the Johns Hopkins Children's Hospital in Baltimore, MD.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Nutritional Management for Individuals with CF: Practical Applications appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2017-06-2822 mineCysticFibrosis ReviewAdherence – What You Should be Telling Your PatientsVolume 7, Issue 4.Our guest author is Gregory Sawicki, MD, MPH from Boston Children's Hospital, and Harvard Medical School in Boston, MA.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Adherence – What You Should be Telling Your Patients appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2017-04-2535 mineCysticFibrosis ReviewWeighing the Options in Managing ExacerbationsVolume 7, Issue 2.Our guest authors are Mark T. Jennings, MD, MHS and Rebecca Dezube, MD from the Johns Hopkins University School of Medicine in Baltimore, MD.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Weighing the Options in Managing Exacerbations appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2017-02-2826 mineCysticFibrosis ReviewFuture Landscape of CFTR ModulatorsVolume 6, Issue 12.Claire Wainwright, FRACP, MD and Tonia Douglas, MD cover the important topic of the Future Landscape of CFTR Modulators in the format of case-study scenarios for the clinical practice.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Future Landscape of CFTR Modulators appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-11-1731 mineCysticFibrosis ReviewPseudomonas aeruginosa Eradication and Outcomes: Key QuestionsVolume 6, Issue 10.Christopher Oermann, MD covers the important topic of the Pseudomonas Eradication in the format of case-study scenarios for the clinical practice.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Pseudomonas aeruginosa Eradication and Outcomes: Key Questions appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-09-1524 mineCysticFibrosis ReviewNutritional Issues in Cystic FibrosisVolume 6, Issue 8.Dr. Deepak Agrawal, MD covers the important topic of Nutritional Issues in Cystic Fibrosis in the format of case-study scenarios for the clinical practice.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Nutritional Issues in Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-07-1410 mineCysticFibrosis ReviewTrends in Inhaled Antibiotic TherapyVolume 6, Issue 6.Daniel Heintz, MD and Karen McCoy, MD cover the important topic of Trends in Inhaled Antibiotic Therapy in the format of case-study scenarios for the clinical practice.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Trends in Inhaled Antibiotic Therapy appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-05-1728 mineCysticFibrosis ReviewPulmonary Exacerbations and the Microbiology of the CF LungVolume 6, Issue 4.Our guest author is John J. LiPuma from the University of Michigan in Ann Arbor, Michigan.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post Pulmonary Exacerbations and the Microbiology of the CF Lung appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-03-3022 mineCysticFibrosis ReviewThe Current State of CFTR ModificationVolume 6, Issue 2.In this issue we are joined by one of our Program Directors, Dr. Noah Lechtzin from the Johns Hopkins University. Dr. Lechtzin will address the current state of CFTR modification and how it can be applied in practice.Take our post-test to claim CME credits:Physician post-testNurse post-testTo read a companion newsletter click here.The post The Current State of CFTR Modification appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2016-01-2822 mineCysticFibrosis ReviewBreaking Coverage of CAT trialSpecial Edition 2015, Part 4.Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. Stuart Elborn of Queen's University in Belfast, Ireland. Dr. Elborn discusses the implications of the CAT study and how it effects his practice.The post Breaking Coverage of CAT trial appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-12-2206 mineCysticFibrosis ReviewBreaking Coverage of CAT trialSpecial Edition 2015, Part 3.Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. JP Clancy of Cincinnati Children's Hospital. Dr. Clancy discusses the implications of the CAT study and how it effect his practice.The post Breaking Coverage of CAT trial appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-12-2205 mineCysticFibrosis ReviewBreaking Coverage of CAT trialSpecial Edition 2015, Part 2.Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. Scott Bell of the QIMR Berghofer Medical Research Institute. Dr. Bell discusses the implications of the CAT study and how it will effect his practice.The post Breaking Coverage of CAT trial appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-12-2205 mineCysticFibrosis ReviewBreaking Coverage of CAT trialSpecial Edition 2015, Part 1.Join us as Dr. Peter Mogayzel of the Johns Hopkins University discusses the design and findings for the CAT study with Dr. Patrick Flume of the Medical University of South Carolina. Learn about the importance of the study and how it may effect your practice.The post Breaking Coverage of CAT trial appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-12-2211 mineCysticFibrosis ReviewAgents for the management of Pseudomonas aeruginosa infectionVolume 5, Issue 14.In this issue we are joined by Dr. Shawn Aaron of University of Ottawa in Ontario, Canada. Dr. Aaron will discuss infection in patients with optimal therapy of chronic Pseudomonas aeruginosa cystic fibrosis, describe the pathophysiology of pulmonary exacerbations associated with Pseudomonas infection in patients with cystic fibrosis, and evaluate the optimal choice of antibiotics to treat Pseudomonas-associated pulmonary exacerbations in patients with cystic fibrosis.The post Agents for the management of Pseudomonas aeruginosa infection appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-11-1933 mineCysticFibrosis ReviewBenefits of CFTR Modification Beyond FEV1 ImprovementVolume 5, Issue 12.In this issue of eCysticfibrosis Review Dr. Chris Goss of the University of Washington Medical Center. Dr. Goss discusses the benefits of CFTR modification beyond Fev1 improvement through the use of patient-cases.The post Benefits of CFTR Modification Beyond FEV1 Improvement appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-09-3026 mineCysticFibrosis ReviewThe Effects of CFTR-modifying TherapiesVolume 5, Issue 10.In this issue of eCystifibrosis Review we will be join by Dr. Stuart Elborn of Queens University in Belfast, Northern Ireland. Dr. Elborn discusses the effects of CFTR-Modifying Therapies. He will present three patient-case scenarios and identify appropriate treatment options.The post The Effects of CFTR-modifying Therapies appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-08-2032 mineCysticFibrosis ReviewOptimizing Nutrition in Individuals with Cystic FibrosisVolume 5, Issue 8.In this issue of eCysticFibrosis Review Dr. John Pohl discuses how to optimize nutrition in individuals with CF. Through patient case-scenarios he applies best practices to achieve optimal nutrition using PERT dosing.The post Optimizing Nutrition in Individuals with Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-06-2323 mineCysticFibrosis ReviewImproving digestive capabilities in nutritionally compromised patients with CFVolume 5, Issue 6.In this issue Dr. Steven Freedman, Professor of Medicine from Harvard Medical School discusses digestive capabilities in nutritionally compromised patients with CF. Listen in as Dr. Freedman explains the importance of pancreatic enzyme replacement and present patient scenarios and best practices of treatment.The post Improving digestive capabilities in nutritionally compromised patients with CF appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-04-1627 mineCysticFibrosis ReviewP. aeruginosa eradication and reinfectionVolume 5, Issue 4.In this issue of eCysticfibrosis Review Dr. Ratjen discusses the challenges of P. aeruginosa eradication. He explains the importance to treat early and available treatment options. He also addresses whether treatment should be repeated in patients who develop recurrence of infection and how to handle patients failing eradication therapy.The post P. aeruginosa eradication and reinfection appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2015-02-2626 mineCysticFibrosis ReviewPulmonary exacerbations: diagnoses, and therapeutic regimensVolume 5, Issue 2.In this podcast Dr. Patrick Flume, Professor of Medicine and Pediatrics at the Medical University of South Carolina in Charleston, discusses pulmonary exacerbation. He provides patient case scenarios to understand the importance of pulmonary exacerbation and the ability to identify when it occurs.The post Pulmonary exacerbations: diagnoses, and therapeutic regimens appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-12-2636 mineCysticFibrosis ReviewWhat Does CFTR Tell Us About Lung Disease?Volume 4, Issue 12.In this issue our guest author is Dr. Patrick Sosnay, Assistant Professor at the Johns Hopkins Cystic Fibrosis Center. Dr. Sosnay will illustrate how the genetics of CF can be used to make a diagnosis or identify a CF carrier, predict how individuals with a given mutation will do clinically and allow clinicians to select currently available and hopefully future therapies that directly address the defect caused by their individual CFTR mutations.The post What Does CFTR Tell Us About Lung Disease? appeared first on DKBmed Radio. Hosted on Acast...2014-04-0837 mineCysticFibrosis ReviewBehavioral Treatment to Improve Dietary Adherence and Weight Gain in Children with Cystic FibrosisVolume 4, Issue 10.In this podcast we have guest author Lori Stark, PhD, ABPP, Professor of Pediatrics at the University of Cincinnati College of Medicine. Dr. Stark, discusses how to use “shaping” to encourage a child to eat a non-preferred food, describes the role of “attention” in maintaining behaviors incompatible with eating, and discusses the use of caloric goal-setting and dietary tracking applications to monitor treatment progress.The post Behavioral Treatment to Improve Dietary Adherence and Weight Gain in Children with Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/priv...2014-02-1131 mineCysticFibrosis ReviewHighlights of the 27th Annual North American Cystic Fibrosis ConferenceSpecial Edition 2014 – Steven Rowe.In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses data findings from Dr. Steven Rowe results of the G551D observational study presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.The post Highlights of the 27th Annual North American Cystic Fibrosis Conference appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-01-0814 mineCysticFibrosis ReviewSpecial Edition 2014 - Steven Rowe: Highlights of the 27th Annual North American Cystic Fibrosis ConferenceSpecial Edition 2014 – Steven Rowe.In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses data findings from Dr. Steven Rowe results of the G551D observational study presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.The post Highlights of the 27th Annual North American Cystic Fibrosis Conference appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-01-0814 mineCysticFibrosis ReviewHighlights of the 27th Annual North American Cystic Fibrosis ConferenceSpecial Edition 2014 – Scott Powers.In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses findings from Dr. Scott Powers clinical trial on Behavioral & Nutrition Treatment for Preschoolers With CF which he presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.The post Highlights of the 27th Annual North American Cystic Fibrosis Conference appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-01-0814 mineCysticFibrosis ReviewHighlights of the 27th Annual North American Cystic Fibrosis ConferenceSpecial Edition 2014 – Elizabeth Yen.In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses outcomes presented by Dr. Elizabeth during her presentation on Nutritional Status and Outcomes in Pediatrics CF presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.The post Highlights of the 27th Annual North American Cystic Fibrosis Conference appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-01-0812 mineCysticFibrosis ReviewHighlights of the 27th Annual North American Cystic Fibrosis ConferenceSpecial Edition 2014 – Kenneth Olivier.In this special edition of eCystic Fibrosis review, Dr. Peter Mogayzel discusses highlights from Dr. Kenneth Olivier's talk on Nontuberculosis Mycobacteria: Updates in CF presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.The post Highlights of the 27th Annual North American Cystic Fibrosis Conference appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2014-01-0815 mineCysticFibrosis ReviewNew Therapies in Cystic Fibrosis Directed Toward the Basic DefectVolume 4, Issue 8.In this podcast guest author Steven Rowe, MD, Associate Professor of Medicine from the University of Alabama at Birmingham, describes how CFTR modulator therapy fits into the clinical armamentarium of CF lung disease; identifies which patients are most appropriate for CF modulator treatment; and describes current research efforts and how to identify patients suitable for referral for consideration in CFTR modulator clinical trials.The post New Therapies in Cystic Fibrosis Directed Toward the Basic Defect appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2013-11-2627 mineCysticFibrosis ReviewP. aeruginosa EradicationVolume 4, Issue 6.In this podcast guest author Dr. Margaret Rosenfeld from the University of Washington School of Medicine, discusses the rationale for early Pseudomonas aeruginosa eradication, Identifies the inhaled and oral antibiotics that have been compared in clinical trials for early Pseudomonas eradication, and describes the potential adverse effects of early Pseudomonas eradication therapy.The post P. aeruginosa Eradication appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2013-07-3028 mineCysticFibrosis ReviewStrategies for the Improvement of Nutrition OutcomesVolume 4, Issue 4.In this podcast guest author Amanda Radmer Leonard, Pediatric Nutrition Practitioner, of the Johns Hopkins Children’s Center, describes approaches to the treatment of low vitamin D levels in patients with cystic fibrosis, discuss the variability of fecal elastase result during the first year of life, and summarizes the importance of tailoring nutritional interventions to specific patient and family situations.The post Strategies for the Improvement of Nutrition Outcomes appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2013-05-2924 mineCysticFibrosis ReviewAdherence to Chronic Inhaled TherapiesVolume 4, Issue 2.Nonadherence to any medical regimen is common particularly among adolescents and young adults, and cystic fibrosis (CF) is no exception. There are many barriers to following the complex daily regimen that CF management requires, and researchers and clinicians have not yet found the ideal approach for counseling and supporting patients to improve and maintain their level of adherence. In this podcast Dr. Kristin Riekert, of The Johns Hopkins Adherence Research Center discusses best practices for determining which clinic patients are nonadherent and Identifies risk factors for nonadherence.The post Adherence to Chronic Inhaled...2013-03-2830 mineCysticFibrosis ReviewFeatured Cases: Emerging Pathogens in Cystic FibrosisVolume 3, Issue 12.Case studies offer opportunity to differentiate the needs of each patient when managing respiratory infections. Dr. Elliott Dasenbrook will review the prevalence of important CF organisms over the last 10 years, the impact of respiratory tract MRSA on survival, the association between a virulent strain of P. aeruginosa that can spread among patients and lung transplant or death, as well as the impact of chronic non-tuberculous Mycobacterial lung disease on lung function.The post Featured Cases: Emerging Pathogens in Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast...2012-07-2341 mineCysticFibrosis ReviewFeatured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CFVolume 3, Issue 10.Dr. Elizabeth Yen offers a clinical perspective to her review on how new research that highlights the strong positive impact of early behavioral and nutritional education and predictors of long-term response to such interventions. In this podcast she will expand on that information by discussing case scenarios.The post Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2012-05-2232 mineCysticFibrosis ReviewFeatured Cases: Interventions to Improve Nutrition in Patients with CFVolume 3, Issue 8.In this issue, Dr. Elizabeth Yen reviews new research highlighting the strong positive impact of early behavioral and nutritional education. Exploring predictors of long-term response to such interventions she discusss how body image may affect compliance with nutritional recommendations in adolescents; and, then present data describing positive outcomes with gastrostomy tube placement for supplemental enteral intake.The post Featured Cases: Interventions to Improve Nutrition in Patients with CF appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2012-03-2036 mineCysticFibrosis ReviewFeatured Cases: Modifiers of CF Lung DiseaseVolume 3, Issue 6.Drs. Cutting and Collaco will help expand our understanding of the genotypic and phenotypic modifiers in the treatment of cystic fibrosis, with the discussion some typical case scenarios.The post Featured Cases: Modifiers of CF Lung Disease appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2012-01-1737 mineCysticFibrosis ReviewFeatured Cases: Exacerbation TherapiesVolume 3, Issue 4.This podcast has been developed for clinicians caring for patients with issues related to cystic fibrosis. You can also read the companion newsletter. In this edition Dr. Chris Goss will explain the use of new inhalation therapies for the treatment of cystic fibrosis, with the discussion some typical case scenarios.The post Featured Cases: Exacerbation Therapies appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2011-11-1829 mineCysticFibrosis ReviewFeatured Cases: New Inhalation TherapiesVolume 2, Issue 12.The eCysticFibrosis Review podcast is a clinical discussion between our November authors, Michael Boyle, MD, Elliott Dasenbrook, MD and Robert Busker, eCysticFibrosis Reviews Medical Editor. The topic is Emerging Pathogens in Cystic Fibrosis. Participants can now receive 0.5 credits per podcast after completing an online post-test via the links provided on the website page, eCysticFibrosisReview.org.The post Featured Cases: New Inhalation Therapies appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2010-12-0235 mineCysticFibrosis ReviewFeatured Cases: State-of-the-Art Treatment for CF Lung DiseaseVolume 2, Issue 10.Clinical practice guidelines have become a regular component of health care. The Cystic Fibrosis Foundation has supported the development of several recent clinical practice guidelines to review the evidence that endorses many of the therapies currently in use.Although numerous clinical manifestations of cystic fibrosis (CF) exist, the principal causes of disease-related morbidity and mortality are due to pancreatic insufficiency and chronic airway infection. Recommendations are now available on the assessment and treatment of nutritional disease, use of airway clearance therapies, and use of chronic medications to maintain lung health. Acute complications of...2010-09-1441 mineCysticFibrosis ReviewFeatured Cases: Vitamin D and Bone HealthVolume 2, Issue 8.In 2002, the CF Foundation convened a consensus conference. This consensus conference developed specific recommendations for the prevention of bone disease and the optimal supplementation of vitamin D for patients with cystic fibrosis. The original consensus guidelines did not have any actual demonstration in cystic fibrosis patients, and most of this was expert opinion. And at this time we are actually trying to test these guidelines to see if they hold true in those with cystic fibrosis. Since patients with cystic fibrosis are living longer, they are developing more complications, such as bone disease, and insuring...2010-07-1326 mineCysticFibrosis ReviewFeatured Cases: Nutritional Challenges and Complications in Patients with CFVolume 2, Issue 6.Improvements in nutrition have been a key factor in reducing morbidity and mortality in patients with cystic fibrosis (CF.) In this issue, Dr. Sarah Jane Schwarzenberg will summarize current progress in the definition and epidemiology of 2 CF GI-related issues—small intestinal bowel overgrowth (SIBO) and distal intestinal obstruction syndrome. The discussion continues with case studies to illustrate causes of nonpancreatic enzyme–related defects in fat absorption, including the use of omega-3 supplements.The post Featured Cases: Nutritional Challenges and Complications in Patients with CF appeared first on DKBmed Radio. Hosted on A...2010-05-1334 mineCysticFibrosis ReviewFeatured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA)Volume 2, Issue 4.In this edition Dr. Richard Moss will help expand our understanding of allergic bronchopulmonary aspergillosis (ABPA) with the discussion some typical case scenarios. ABPA is a major pulmonary complication in patients with cystic fibrosis (CF). The impact of ABPA on the course of CF lung disease poses special challenges, with chronic Aspergillus respiratory infection, even in the absence of ABPA, playing a significant role, according to data from 2 recent retrospective cohort studies. Dr. Moss' use of current diagnostic criteria provides perspective also on the limitations.The post Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA...2010-03-0933 mineCysticFibrosis ReviewFeatured Cases: Cystic Fibrosis–Related DiabetesVolume 2, Issue 2.In September of 2009, the Cystic Fibrosis Foundation held a third CFRD consensus conference, co-sponsored by the American Diabetes Association and the Lawson Wilkins Pediatric Endocrine Society, providing a new set of recommendations for treating cystic fibrosis-related diabetes. Johns Hopkins provided evidence review so there can be evidence-based guidelines. Diagnostic & treatment criteria are presented in this podcast.The post Featured Cases: Cystic Fibrosis–Related Diabetes appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2010-01-1230 mineCysticFibrosis ReviewMeasurement of Early Lung Disease in Children With Cystic FibrosisVolume 1, Issue 5.The eCysticFibrosis Review podcast is a clinical discussion between our January authors, Stephanie D. Davis, MD, Jessica Pittman, MD and Robert Busker, eCysticFibrosis Reviews Medical Editor. The topic is Measurement of Early Lung Disease in Children With Cystic Fibrosis. Participants can now receive 0.5 credits per podcast after completing an online post-test via the links provided on this page via eCysticFibrosisReview.org.The post Measurement of Early Lung Disease in Children With Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2009-01-1526 mineCysticFibrosis ReviewEmerging Pathogens in Cystic FibrosisVolume 1, Issue 4.The eCysticFibrosis Review podcast is a clinical discussion between our November authors, Michael Boyle, MD, Elliott Dasenbrook, MD and Robert Busker, eCysticFibrosis Reviews Medical Editor. The topic is Emerging Pathogens in Cystic Fibrosis. Participants can now receive 0.5 credits per podcast after completing an online post-test via the links provided on the website page, eCysticFibrosisReview.org.The post Emerging Pathogens in Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2008-11-1332 mineCysticFibrosis ReviewHow to Interpret Genetic Tests for Cystic FibrosisVolume 1, Issue 3.The eCysticFibrosis Review podcast is a clinical discussion between our September authors, Garry Cutting, MD, Barbara Karczeski, MS and Robert Busker, eCysticFibrosis Reviews Medical Editor. The topic is How to Interpret Genetic Testing for Cystic Fibrosis. Participants can now receive 0.5 credits per podcast after completing an online post-test via the links provided on the website page, eCysticFibrosisReview.orgThe post How to Interpret Genetic Tests for Cystic Fibrosis appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2008-09-1839 min